Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

BioTheranostics

BioTheranostics?uq=PEM9b6PF
1996 FOUNDED
M&A STATUS
101-200 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$5.97M LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of commercial-stage molecular diagnostics system designed to offer predictive tests for cancer treatment. The company's commercial-stage molecular diagnostics provides diagnostic, prognostic, predictive tests and offers evidence-based biomarkers, enabling doctors to address unmet medical needs.

Formerly Known As
SDL Acquisition, AviaraDX
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Diagnostic Equipment
Parent Company
Primary Office
  • 9640 Towne Centre Drive
  • Suite 200
  • San Diego, CA 92121
  • United States

+1 (877) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore BioTheranostics’s full profile, request a free trial.

BioTheranostics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 10-Aug-2018 $5.97M 0000 Completed
3. Later Stage VC 21-Jan-2016 0000 0000 0000 Completed Generating Revenue
2. Merger/Acquisition 11-Sep-2008 $60M $8M 0000 Completed Generating Revenue
1. Early Stage VC (Series A) 19-Nov-2007 $8M $8M 0000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

BioTheranostics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 000,000,000 00.000000 000 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

BioTheranostics Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
ABS Capital Partners Growth/Expansion Minority 000 0000 000000 0
SDL Ventures Venture Capital Minority 000 0000 000000 0

BioTheranostics Executive Team (13)

Name Title Board
Seat
Contact
Info
Donald Hardison President, Chief Executive Officer & Board Member
Gail Sloan Chief Financial Officer
Andy Lavagnino Contract Controller
Catherine Schnabel Chief Scientific Officer
Debra Hadley Vice President, Laboratory Operations

4 Former Executives

You’re viewing 5 of 13 executives. Get the full list »

BioTheranostics Board Members (8)

Name Representing Role Since Contact
Info
Adam Lessler MD Canepa Healthcare Board Observer 000 0000
Alejandro Sanchez Canepa Healthcare Board Member 000 0000
Brad Smith Self Board Member 000 0000
Brian Armstrong BioMérieux Board Member 000 0000
David Kabakoff Ph.D HealthQuest Capital Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 8 board members. Get the full list »